Indaptus Therapeutics, Inc. announced that it has entered into a purchase agreement with Lincoln Park Capital Fund, LLC, a fund managed by Lincoln Park Capital, LLC for a private placement of common shares of $0.01 par value in an equity line transaction for proceeds of $20,000,000 on December 22, 2022. The shares will be issued over a 36-month period.

On the same date, the company issued 142,450 shares of common stock to the investor as commitment shares.